Abstract
Aim: To evaluate the clinical impact of the use of the Caiman® articulating energy device in advanced ovarian cancer (AOC) including rectosigmoid resection [e.g. modified posterior exenteration (MPE)]. Patients and Methods: This was a prospective single-institution observational study with women undergoing MPE where all soft-tissue dissections and vessel ligations were performed using the Caiman® device. Intraoperative and postoperative surgical data were collected. Bladder function after nervesparing surgery was analyzed before and 6 months after surgery. Results: Forty patients were registered in the study. The median time for specimen removal using Caiman® was 86 min (range=70-120 min). Major vessel ligation was successful in all patients with a median of a single (range=1-4) Caiman® application to seal major vessels. No intraoperative or postoperative complications or bladder dysfunctions associated with the use of Caiman® were noted. Conclusion: Caiman® can be safely used in AOC surgery and may save time through faster dissection. However, comparative studies with other energy devices are needed to confirm this finding.
| Original language | English |
|---|---|
| Pages (from-to) | 359-364 |
| Number of pages | 6 |
| Journal | In Vivo |
| Volume | 32 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Mar 1 2018 |
Fingerprint
Keywords
- Caiman®
- Energy device
- Ovarian cancer
- Surgery
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Pharmacology
Cite this
Clinical impact of a surgical energy device in advanced ovarian cancer surgery including bowel resection. / Vizzielli, Giuseppe; Conte, Carmine; Romano, Massimo; Fagotti, Anna; Costantini, Barbara; Lodoli, Claudio; Alletti, Salvatore Gueli; Gaballah, Khaled; Pacelli, Fabio; Ercoli, Alfredo; Scambia, Giovanni; Gallotta, Valerio.
In: In Vivo, Vol. 32, No. 2, 01.03.2018, p. 359-364.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Clinical impact of a surgical energy device in advanced ovarian cancer surgery including bowel resection
AU - Vizzielli, Giuseppe
AU - Conte, Carmine
AU - Romano, Massimo
AU - Fagotti, Anna
AU - Costantini, Barbara
AU - Lodoli, Claudio
AU - Alletti, Salvatore Gueli
AU - Gaballah, Khaled
AU - Pacelli, Fabio
AU - Ercoli, Alfredo
AU - Scambia, Giovanni
AU - Gallotta, Valerio
PY - 2018/3/1
Y1 - 2018/3/1
N2 - Aim: To evaluate the clinical impact of the use of the Caiman® articulating energy device in advanced ovarian cancer (AOC) including rectosigmoid resection [e.g. modified posterior exenteration (MPE)]. Patients and Methods: This was a prospective single-institution observational study with women undergoing MPE where all soft-tissue dissections and vessel ligations were performed using the Caiman® device. Intraoperative and postoperative surgical data were collected. Bladder function after nervesparing surgery was analyzed before and 6 months after surgery. Results: Forty patients were registered in the study. The median time for specimen removal using Caiman® was 86 min (range=70-120 min). Major vessel ligation was successful in all patients with a median of a single (range=1-4) Caiman® application to seal major vessels. No intraoperative or postoperative complications or bladder dysfunctions associated with the use of Caiman® were noted. Conclusion: Caiman® can be safely used in AOC surgery and may save time through faster dissection. However, comparative studies with other energy devices are needed to confirm this finding.
AB - Aim: To evaluate the clinical impact of the use of the Caiman® articulating energy device in advanced ovarian cancer (AOC) including rectosigmoid resection [e.g. modified posterior exenteration (MPE)]. Patients and Methods: This was a prospective single-institution observational study with women undergoing MPE where all soft-tissue dissections and vessel ligations were performed using the Caiman® device. Intraoperative and postoperative surgical data were collected. Bladder function after nervesparing surgery was analyzed before and 6 months after surgery. Results: Forty patients were registered in the study. The median time for specimen removal using Caiman® was 86 min (range=70-120 min). Major vessel ligation was successful in all patients with a median of a single (range=1-4) Caiman® application to seal major vessels. No intraoperative or postoperative complications or bladder dysfunctions associated with the use of Caiman® were noted. Conclusion: Caiman® can be safely used in AOC surgery and may save time through faster dissection. However, comparative studies with other energy devices are needed to confirm this finding.
KW - Caiman®
KW - Energy device
KW - Ovarian cancer
KW - Surgery
UR - http://www.scopus.com/inward/record.url?scp=85045736798&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045736798&partnerID=8YFLogxK
U2 - 10.21873/invivo.11246
DO - 10.21873/invivo.11246
M3 - Article
C2 - 29475921
AN - SCOPUS:85045736798
VL - 32
SP - 359
EP - 364
JO - In Vivo
JF - In Vivo
SN - 0258-851X
IS - 2
ER -